269 related articles for article (PubMed ID: 34172755)
1. Neuronal and glial 3D chromatin architecture informs the cellular etiology of brain disorders.
Hu B; Won H; Mah W; Park RB; Kassim B; Spiess K; Kozlenkov A; Crowley CA; Pochareddy S; ; Li Y; Dracheva S; Sestan N; Akbarian S; Geschwind DH
Nat Commun; 2021 Jun; 12(1):3968. PubMed ID: 34172755
[TBL] [Abstract][Full Text] [Related]
2. Common schizophrenia risk variants are enriched in open chromatin regions of human glutamatergic neurons.
Hauberg ME; Creus-Muncunill J; Bendl J; Kozlenkov A; Zeng B; Corwin C; Chowdhury S; Kranz H; Hurd YL; Wegner M; Børglum AD; Dracheva S; Ehrlich ME; Fullard JF; Roussos P
Nat Commun; 2020 Nov; 11(1):5581. PubMed ID: 33149216
[TBL] [Abstract][Full Text] [Related]
3. The genome in three dimensions: a new frontier in human brain research.
Mitchell AC; Bharadwaj R; Whittle C; Krueger W; Mirnics K; Hurd Y; Rasmussen T; Akbarian S
Biol Psychiatry; 2014 Jun; 75(12):961-9. PubMed ID: 23958183
[TBL] [Abstract][Full Text] [Related]
4. Chromosome conformation elucidates regulatory relationships in developing human brain.
Won H; de la Torre-Ubieta L; Stein JL; Parikshak NN; Huang J; Opland CK; Gandal MJ; Sutton GJ; Hormozdiari F; Lu D; Lee C; Eskin E; Voineagu I; Ernst J; Geschwind DH
Nature; 2016 Oct; 538(7626):523-527. PubMed ID: 27760116
[TBL] [Abstract][Full Text] [Related]
5. Open chromatin profiling of human postmortem brain infers functional roles for non-coding schizophrenia loci.
Fullard JF; Giambartolomei C; Hauberg ME; Xu K; Voloudakis G; Shao Z; Bare C; Dudley JT; Mattheisen M; Robakis NK; Haroutunian V; Roussos P
Hum Mol Genet; 2017 May; 26(10):1942-1951. PubMed ID: 28335009
[TBL] [Abstract][Full Text] [Related]
6. Brain cell type-specific enhancer-promoter interactome maps and disease
Nott A; Holtman IR; Coufal NG; Schlachetzki JCM; Yu M; Hu R; Han CZ; Pena M; Xiao J; Wu Y; Keulen Z; Pasillas MP; O'Connor C; Nickl CK; Schafer ST; Shen Z; Rissman RA; Brewer JB; Gosselin D; Gonda DD; Levy ML; Rosenfeld MG; McVicker G; Gage FH; Ren B; Glass CK
Science; 2019 Nov; 366(6469):1134-1139. PubMed ID: 31727856
[TBL] [Abstract][Full Text] [Related]
7. Epigenetic mechanisms underlying enhancer modulation of neuronal identity, neuronal activity and neurodegeneration.
Alcalà-Vida R; Awada A; Boutillier AL; Merienne K
Neurobiol Dis; 2021 Jan; 147():105155. PubMed ID: 33127472
[TBL] [Abstract][Full Text] [Related]
8. Robust Hi-C Maps of Enhancer-Promoter Interactions Reveal the Function of Non-coding Genome in Neural Development and Diseases.
Lu L; Liu X; Huang WK; Giusti-Rodríguez P; Cui J; Zhang S; Xu W; Wen Z; Ma S; Rosen JD; Xu Z; Bartels CF; Kawaguchi R; Hu M; Scacheri PC; Rong Z; Li Y; Sullivan PF; Song H; Ming GL; Li Y; Jin F
Mol Cell; 2020 Aug; 79(3):521-534.e15. PubMed ID: 32592681
[TBL] [Abstract][Full Text] [Related]
9. Cross-Disorder Analysis of Genic and Regulatory Copy Number Variations in Bipolar Disorder, Schizophrenia, and Autism Spectrum Disorder.
Kushima I; Nakatochi M; Aleksic B; Okada T; Kimura H; Kato H; Morikawa M; Inada T; Ishizuka K; Torii Y; Nakamura Y; Tanaka S; Imaeda M; Takahashi N; Yamamoto M; Iwamoto K; Nawa Y; Ogawa N; Iritani S; Hayashi Y; Lo T; Otgonbayar G; Furuta S; Iwata N; Ikeda M; Saito T; Ninomiya K; Okochi T; Hashimoto R; Yamamori H; Yasuda Y; Fujimoto M; Miura K; Itokawa M; Arai M; Miyashita M; Toriumi K; Ohi K; Shioiri T; Kitaichi K; Someya T; Watanabe Y; Egawa J; Takahashi T; Suzuki M; Sasaki T; Tochigi M; Nishimura F; Yamasue H; Kuwabara H; Wakuda T; Kato TA; Kanba S; Horikawa H; Usami M; Kodaira M; Watanabe K; Yoshikawa T; Toyota T; Yokoyama S; Munesue T; Kimura R; Funabiki Y; Kosaka H; Jung M; Kasai K; Ikegame T; Jinde S; Numata S; Kinoshita M; Kato T; Kakiuchi C; Yamakawa K; Suzuki T; Hashimoto N; Ishikawa S; Yamagata B; Nio S; Murai T; Son S; Kunii Y; Yabe H; Inagaki M; Goto YI; Okumura Y; Ito T; Arioka Y; Mori D; Ozaki N
Biol Psychiatry; 2022 Sep; 92(5):362-374. PubMed ID: 35667888
[TBL] [Abstract][Full Text] [Related]
10. Chromatin domain alterations linked to 3D genome organization in a large cohort of schizophrenia and bipolar disorder brains.
Girdhar K; Hoffman GE; Bendl J; Rahman S; Dong P; Liao W; Hauberg ME; Sloofman L; Brown L; Devillers O; Kassim BS; Wiseman JR; Park R; Zharovsky E; Jacobov R; Flatow E; Kozlenkov A; Gilgenast T; Johnson JS; Couto L; Peters MA; Phillips-Cremins JE; Hahn CG; Gur RE; Tamminga CA; Lewis DA; Haroutunian V; ; Dracheva S; Lipska BK; Marenco S; Kundakovic M; Fullard JF; Jiang Y; Roussos P; Akbarian S
Nat Neurosci; 2022 Apr; 25(4):474-483. PubMed ID: 35332326
[TBL] [Abstract][Full Text] [Related]
11. Sex dependent glial-specific changes in the chromatin accessibility landscape in late-onset Alzheimer's disease brains.
Barrera J; Song L; Gamache JE; Garrett ME; Safi A; Yun Y; Premasinghe I; Sprague D; Chipman D; Li J; Fradin H; Soldano K; Gordân R; Ashley-Koch AE; Crawford GE; Chiba-Falek O
Mol Neurodegener; 2021 Aug; 16(1):58. PubMed ID: 34429139
[TBL] [Abstract][Full Text] [Related]
12. Single-nucleus chromatin accessibility and transcriptomic characterization of Alzheimer's disease.
Morabito S; Miyoshi E; Michael N; Shahin S; Martini AC; Head E; Silva J; Leavy K; Perez-Rosendahl M; Swarup V
Nat Genet; 2021 Aug; 53(8):1143-1155. PubMed ID: 34239132
[TBL] [Abstract][Full Text] [Related]
13. Epigenetically regulated microRNAs in Alzheimer's disease.
Van den Hove DL; Kompotis K; Lardenoije R; Kenis G; Mill J; Steinbusch HW; Lesch KP; Fitzsimons CP; De Strooper B; Rutten BP
Neurobiol Aging; 2014 Apr; 35(4):731-45. PubMed ID: 24238656
[TBL] [Abstract][Full Text] [Related]
14. DNA hypermethylation of serotonin transporter gene promoter in drug naïve patients with schizophrenia.
Abdolmaleky HM; Nohesara S; Ghadirivasfi M; Lambert AW; Ahmadkhaniha H; Ozturk S; Wong CK; Shafa R; Mostafavi A; Thiagalingam S
Schizophr Res; 2014 Feb; 152(2-3):373-80. PubMed ID: 24411530
[TBL] [Abstract][Full Text] [Related]
15. Chromatin profiling of cortical neurons identifies individual epigenetic signatures in schizophrenia.
Gusev FE; Reshetov DA; Mitchell AC; Andreeva TV; Dincer A; Grigorenko AP; Fedonin G; Halene T; Aliseychik M; Filippova E; Weng Z; Akbarian S; Rogaev EI
Transl Psychiatry; 2019 Oct; 9(1):256. PubMed ID: 31624234
[TBL] [Abstract][Full Text] [Related]
16. Location matters: distinct DNA methylation patterns in GABAergic interneuronal populations from separate microcircuits within the human hippocampus.
Ruzicka WB; Subburaju S; Coyle JT; Benes FM
Hum Mol Genet; 2018 Jan; 27(2):254-265. PubMed ID: 29106556
[TBL] [Abstract][Full Text] [Related]
17. The three-dimensional landscape of the genome in human brain tissue unveils regulatory mechanisms leading to schizophrenia risk.
Mah W; Won H
Schizophr Res; 2020 Mar; 217():17-25. PubMed ID: 30894290
[TBL] [Abstract][Full Text] [Related]
18. Epigenetic modifications in frontal cortex from Alzheimer's disease and bipolar disorder patients.
Rao JS; Keleshian VL; Klein S; Rapoport SI
Transl Psychiatry; 2012 Jul; 2(7):e132. PubMed ID: 22760556
[TBL] [Abstract][Full Text] [Related]
19. A unique chromatin signature uncovers early developmental enhancers in humans.
Rada-Iglesias A; Bajpai R; Swigut T; Brugmann SA; Flynn RA; Wysocka J
Nature; 2011 Feb; 470(7333):279-83. PubMed ID: 21160473
[TBL] [Abstract][Full Text] [Related]
20. Chromatin interaction maps reveal genetic regulation for quantitative traits in maize.
Peng Y; Xiong D; Zhao L; Ouyang W; Wang S; Sun J; Zhang Q; Guan P; Xie L; Li W; Li G; Yan J; Li X
Nat Commun; 2019 Jun; 10(1):2632. PubMed ID: 31201335
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
